NO871549L - Medikament for behandling av oeyenbetennelser. - Google Patents

Medikament for behandling av oeyenbetennelser.

Info

Publication number
NO871549L
NO871549L NO87871549A NO871549A NO871549L NO 871549 L NO871549 L NO 871549L NO 87871549 A NO87871549 A NO 87871549A NO 871549 A NO871549 A NO 871549A NO 871549 L NO871549 L NO 871549L
Authority
NO
Norway
Prior art keywords
medicines
treatment
eye injuries
injuries
eye
Prior art date
Application number
NO87871549A
Other languages
English (en)
Other versions
NO871549D0 (no
NO174916B (no
NO174916C (no
Inventor
Johann Doulakas
Original Assignee
Dispersa Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6298657&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO871549(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dispersa Ag filed Critical Dispersa Ag
Publication of NO871549D0 publication Critical patent/NO871549D0/no
Publication of NO871549L publication Critical patent/NO871549L/no
Publication of NO174916B publication Critical patent/NO174916B/no
Publication of NO174916C publication Critical patent/NO174916C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
NO871549A 1986-04-14 1987-04-13 Fremgangsmåte for fremstilling av et medikament for behandling av öyenbetennelser NO174916C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3612537A DE3612537C1 (de) 1986-04-14 1986-04-14 Arzneimittel zur Behandlung von Entzuendungen im Auge

Publications (4)

Publication Number Publication Date
NO871549D0 NO871549D0 (no) 1987-04-13
NO871549L true NO871549L (no) 1987-10-15
NO174916B NO174916B (no) 1994-04-25
NO174916C NO174916C (no) 1994-08-03

Family

ID=6298657

Family Applications (1)

Application Number Title Priority Date Filing Date
NO871549A NO174916C (no) 1986-04-14 1987-04-13 Fremgangsmåte for fremstilling av et medikament for behandling av öyenbetennelser

Country Status (12)

Country Link
US (1) US4829088A (no)
EP (1) EP0242328B1 (no)
JP (1) JP2515788B2 (no)
CA (1) CA1286225C (no)
DE (1) DE3612537C1 (no)
DK (1) DK164639C (no)
EG (1) EG18268A (no)
ES (1) ES2038691T4 (no)
GR (1) GR3002659T3 (no)
NO (1) NO174916C (no)
PT (1) PT84669B (no)
ZA (1) ZA872624B (no)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH675537A5 (no) * 1988-03-25 1990-10-15 Ciba Geigy Ag
US4960799A (en) * 1988-09-13 1990-10-02 Ciba-Geigy Corporation Stabilized aqueous solutions of pharmaceutically acceptable salts of ortho-(2,6-dichlorophenyl)-aminophenylacetic acid for opthalmic use
EP0420798B1 (de) * 1989-09-21 1994-03-23 Ciba Vision AG, Hettlingen Antimikrobielle Zusammensetzungen
US6117907A (en) * 1993-04-14 2000-09-12 Sher; Neal A. Topical treatment of ocular pain after corneal surgery
US5494817A (en) * 1993-12-06 1996-02-27 Allergan, Inc. Sugar-based protease composition for use with constant-PH borate buffers
US5474985A (en) * 1993-12-22 1995-12-12 The Regents Of The University Of California Preventing and treating elevated intraocular pressure associated with administered or endogenous steroids using non-steroidal cyclooxygenase inhibitors
ES2079320B1 (es) * 1994-05-17 1996-10-16 Cusi Lab Disolucion oftalmica a base de un diclofenaco y tobramicina y sus aplicaciones.
US6309630B1 (en) 1994-05-24 2001-10-30 Insite Vision Incorporated Non-steroidal anti-inflammatory ophthalmic suspensions
US5789169A (en) * 1994-11-03 1998-08-04 Regents Of The University Of California Methods for the diagnosis of glaucoma
US5849879A (en) * 1994-11-03 1998-12-15 The Regents Of The University Of California Methods for the diagnosis of glaucoma
US5606043A (en) 1994-11-03 1997-02-25 The Regents Of The University Of California Methods for the diagnosis of glaucoma
DE69526369T2 (de) * 1995-01-20 2002-11-07 Wakamoto Pharma Co Ltd Entzündungshemmende augentropfen
JP3170619B2 (ja) * 1995-04-20 2001-05-28 参天製薬株式会社 有機アミンを配合したプラノプロフェン点眼液
US5620970A (en) * 1995-06-05 1997-04-15 Alcon Laboratories, Inc. Topical ophthalmic carbonic anhydrase inhibitor formulations
US5599535A (en) * 1995-06-07 1997-02-04 Regents Of The University Of California Methods for the cyto-protection of the trabecular meshwork
US5674888A (en) * 1995-06-07 1997-10-07 University Of California Method for the treatment of a trabecular meshwork whose cells are subject to inhibition of cell division
US5686488A (en) * 1995-08-25 1997-11-11 Alcon Laboratories, Inc. Polyethoxylated castor oil products as anti-inflammatory agents
CA2241515A1 (en) * 1995-12-27 1997-07-10 Junko Shima Aqueous composition comprising cromoglycic acid
US5814655A (en) * 1996-11-14 1998-09-29 Insite Vision Incorporated Non-steroidal ophthalmic mixtures
ATE218887T1 (de) * 1996-12-13 2002-06-15 Alcon Lab Inc Verwendung von niedermolekularen aminoalkoholen in ophthalmologischen präparaten
US7138511B1 (en) 1997-01-28 2006-11-21 The Regents Of The University Of California Nucleic acids, kits and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
US6171788B1 (en) 1997-01-28 2001-01-09 The Regents Of The University Of California Methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
US6475724B1 (en) 1997-01-28 2002-11-05 The Regents Of The University Of California Nucleic acids, kits, and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
US6265444B1 (en) 1997-05-23 2001-07-24 Insite Vision Incorporated Ophthalmic composition
DE19729879C2 (de) 1997-07-11 1999-07-08 Mann Gerhard Chem Pharm Fab Lagerstabile ophthalmische Zusammensetzungen, umfassend Diclofenac und Ofloxacin
JP2006111636A (ja) * 1997-12-26 2006-04-27 Astellas Pharma Inc 徐放性医薬組成物
AU1548001A (en) * 1999-11-24 2001-06-04 Wakamoto Pharmaceutical Co., Ltd. Ophthalmic aqueous preparation
PE20020146A1 (es) * 2000-07-13 2002-03-31 Upjohn Co Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2)
US20030119000A1 (en) * 2001-11-05 2003-06-26 Jon Polansky Methods to screen and treat individuals with glaucoma or the propensity to develop glaucoma
US20050119299A1 (en) * 2002-03-08 2005-06-02 Sankyo Company, Limited Ophthalmic solutions containing tetrazole derivatives
TW200304812A (en) * 2002-03-08 2003-10-16 Sankyo Co An eye drop containing a tetrazole derivative
JP4524538B2 (ja) * 2002-04-08 2010-08-18 ライオン株式会社 眼科用組成物
US20040224010A1 (en) * 2002-11-15 2004-11-11 Optime Therapeutics, Inc. Ophthalmic liposome compositions and uses thereof
PE20040844A1 (es) 2002-11-26 2004-12-30 Novartis Ag Acidos fenilaceticos y derivados como inhibidores de la cox-2
KR20130080061A (ko) * 2004-11-05 2013-07-11 센주 세이야꾸 가부시키가이샤 안구 내 이행성 촉진 수성 점안제
US8758816B2 (en) * 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
US20070020330A1 (en) 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
EP2486942B1 (en) 2004-11-24 2018-10-10 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
JP5108234B2 (ja) * 2005-02-07 2012-12-26 日本特殊陶業株式会社 マイクロヒータ及びセンサ
EP1981491A4 (en) * 2006-01-25 2009-09-23 Aciex Inc COMPOSITIONS AND METHODS FOR TREATING OPHTHALMIC DROUGHT
US20100130580A1 (en) * 2006-01-25 2010-05-27 Aciex Therapeutics, Inc. Formulations and Methods for Treating Dry Eye
US20070212420A1 (en) * 2006-03-10 2007-09-13 Bausch & Lomb Incorporated Pharmaceutical formulations comprising polyanionic materials and zinc-based preservatives
US7829249B2 (en) * 2007-03-05 2010-11-09 Asml Netherlands B.V. Device manufacturing method, computer program and lithographic apparatus
TWI465236B (zh) * 2007-03-13 2014-12-21 參天製藥股份有限公司 含有吡諾克辛之懸浮型水性液劑
EP2160182A1 (en) * 2007-05-24 2010-03-10 Aciex Therapeutics, Inc. Formulations and methods for treating dry eye
US20130011469A1 (en) 2009-07-23 2013-01-10 U.S. Nutraceuticals, Llc D/B/A Valensa International Krill oil and carotenoid composition, associated method and delivery system
JP5246182B2 (ja) * 2010-02-24 2013-07-24 ライオン株式会社 点眼剤、防腐剤及び防腐力向上剤
JP5299449B2 (ja) * 2011-02-23 2013-09-25 ライオン株式会社 外用剤組成物
JP2013082682A (ja) * 2011-09-29 2013-05-09 Senju Pharmaceut Co Ltd 亜塩素酸塩を含有する水性製剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU185926B (en) * 1979-09-27 1985-04-28 Agostne Kahan Process for preparing water soluble derivatives of non-steroid antiinflammatory compositions and pharmaceutical compositins containing such derivatives
DE3026402A1 (de) * 1980-07-11 1982-02-04 Syntex Corp., Palo Alto, Calif. Die verwendung analgetischer und nicht-hormonaler, entzuendungshemmender mittel bei der behandlung von mikrovaskulaeren erkrankungen
JPS58174309A (ja) * 1982-04-06 1983-10-13 Wakamoto Pharmaceut Co Ltd 消炎点眼剤
JPS58174310A (ja) * 1982-04-06 1983-10-13 Wakamoto Pharmaceut Co Ltd 抗炎症点眼剤

Also Published As

Publication number Publication date
DK176487D0 (da) 1987-04-07
EP0242328A2 (de) 1987-10-21
ES2038691T3 (es) 1993-08-01
ES2038691T4 (es) 1995-09-01
NO871549D0 (no) 1987-04-13
DK164639B (da) 1992-07-27
DE3612537C1 (de) 1987-07-16
ZA872624B (en) 1987-12-30
US4829088A (en) 1989-05-09
PT84669A (en) 1987-05-01
NO174916B (no) 1994-04-25
JPS62242617A (ja) 1987-10-23
DK176487A (da) 1987-10-15
NO174916C (no) 1994-08-03
EP0242328B1 (de) 1991-07-24
JP2515788B2 (ja) 1996-07-10
EP0242328A3 (en) 1988-04-06
GR3002659T3 (en) 1993-01-25
CA1286225C (en) 1991-07-16
DK164639C (da) 1992-12-21
EG18268A (en) 1993-02-28
PT84669B (pt) 1989-11-30

Similar Documents

Publication Publication Date Title
NO871549D0 (no) Medikament for behandling av oeyenbetennelser.
DE3783437T2 (de) Heilmittel.
DE3789320T2 (de) Verabreichungsinstrument zum Einführen von festen Medikamenten.
NO875082L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridinoksimer.
FI875326A (fi) Ljusbestraolningsanordning foer medicinal vaord av oera.
FI880195A0 (fi) Terapeutiska produkter.
DE68909970T2 (de) Hautbehandlungsmittel.
FI875039A (fi) Terapeutiska sammansaettningar foer veterinaermedicinsk anvaendning.
NO873108D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,4-benzodiazepiner.
IT8721115A0 (it) Fitopreparato per la cura di affezioni cutanee.
DE3763519D1 (de) Heilnahrungsmittel.
NO873835D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive karbocykliske pyridiner.
NO880292D0 (no) Fremgangsmaate for behandling av humle.
NO881255L (no) Behandling av fluider.
NO900771D0 (no) Anordning for behandling av krympeplast.
NO165917C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktivt diamino-2,2-difluorhex-5-yn.
NO884635D0 (no) Fremgangsmaate for behandling av most.
DE3668338D1 (de) Kontinuierliche behandlung von spannungslosem gewebe.
NO885031D0 (no) FremgangsmŸte for behandling av en polysakkaridvŸske.
NO166715C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cytorodin s derivater.
DK469487A (da) Laegemiddel til behandling af fedme
RO94684A2 (ro) Medicament pentru tratamentul unor dermatoze
FI863561A0 (fi) Anordning foer foerlaettande av gaong med laorprotes.
FI864493A0 (fi) Anordning foer sterilisering av vaetska med uv-ljus.
NO902968D0 (no) Fremgangsmaate for behandling av boreslam.